Centrus Energy rises after Q1 beat as uranium enrichment demand lifts outlook

Centrus Energy shares rose to $216.75 from $206.04 after the company’s first-quarter results topped Wall Street revenue and profit expectations, supported by demand from commercial and government customers and progress in domestic uranium enrichment. Management cited advances in its centrifuge manufacturing program and new external partnerships, including work tied to Palantir and Fluor, as key areas for execution in coming quarters. CEO Amir Vexler said the company sees an opportunity to rebuild U.S. leadership in uranium enrichment. Investors are watching the pace of new contract wins, revenue conversion from government and commercial customers, cost-saving execution, workforce expansion and manufacturing facility build-outs. Development of the high-assay low-enriched uranium, or HALEU, market and regulatory decisions remain key catalysts for Centrus Energy.